VTVT

vTv Therapeutics (VTVT)

vTv Therapeutics Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:VTVT

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	05 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/06/14	05 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/06/14	05 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/05/28	21 : 00	PR Newswire (US)	CANTEX PHARMACEUTICALS ANNOUNCES FOUR ABSTRACTS TO BE PRESENTED FEATURING AZELIRAGON AT 2024 ASCO ANNUAL MEETING	NASDAQ:VTVT	vTv Therapeutics Inc
2024/05/10	05 : 51	GlobeNewswire Inc.	vTv Therapeutics Announces 2024 First Quarter Financial Results and Provides Corporate Update	NASDAQ:VTVT	vTv Therapeutics Inc
2024/05/10	05 : 32	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VTVT	vTv Therapeutics Inc
2024/05/10	05 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/19	21 : 30	PR Newswire (US)	CANTEX PHARMACEUTICALS TO PRESENT AT 5TH ANNUAL GLIOBLASTOMA DRUG DEVELOPMENT SUMMIT	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/13	21 : 00	GlobeNewswire Inc.	vTv Therapeutics Announces 2023 Fourth Quarter and Full Year Financial Results and Provides Corporate Update	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/08	06 : 47	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/08	04 : 34	Edgar (US Regulatory)	Form D - Notice of Exempt Offering of Securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/06	09 : 52	Edgar (US Regulatory)	Form SC 13D - General statement of acquisition of beneficial ownership	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/05	22 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/04	22 : 00	GlobeNewswire Inc.	vTv Therapeutics Announces FDA Submission for First Phase 3 Study of Cadisegliatin in Patients with Type 1 Diabetes	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/01	22 : 00	GlobeNewswire Inc.	vTv Therapeutics to Participate at the TD Cowen 44th Annual Healthcare Conference	NASDAQ:VTVT	vTv Therapeutics Inc
2024/03/01	09 : 34	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	23 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	23 : 14	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	22 : 08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/28	22 : 00	GlobeNewswire Inc.	vTv Therapeutics Announces $51 Million Private Placement from Healthcare-focused Institutional Investors and the JDRF T1D Fund	NASDAQ:VTVT	vTv Therapeutics Inc
2024/02/23	06 : 00	PR Newswire (US)	CANTEX PHARMACEUTICALS TO PARTICIPATE IN THE BIO CEO & INVESTOR CONFERENCE	NASDAQ:VTVT	vTv Therapeutics Inc
2023/12/23	06 : 26	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/12/20	06 : 28	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/12/13	06 : 21	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/21	06 : 23	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/15	22 : 22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/15	22 : 19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/10	06 : 30	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/10	06 : 30	GlobeNewswire Inc.	vTv Therapeutics Announces 2023 Third Quarter Financial Results and Provides Corporate Update	NASDAQ:VTVT	vTv Therapeutics Inc
2023/11/10	06 : 20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:VTVT	vTv Therapeutics Inc